- Registration Date 2016-03-24
- Hit 5633
Company Information |
|
1. Name |
MEDIPOST Co., Ltd. |
2. Website Address |
http://www.medi-post.com |
3. Location |
21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea |
4. Contacts |
http://www.medi-post.com/stem-cell-therapy-qna/ |
5. References |
|
Pharmaceutical Product Information |
|
1. Brand Name |
CARTISTEM® |
2. Active Ingredient |
Human Umbilical Cord Blood-derived Mesenchymal Stem Cells, 7.5x106 cells/vial |
3. Indication |
For the treatment of knee articular cartilage defects in patients with osteoarthritis (ICRS grade IV) as a result of degenerative disease or repeated trauma |
4. Information |
CARTISTEM®is a drug based on allogeneic umbilical cord blood derived mesenchymal stem cells. It is indicated to treat knee cartilage defects as a result of degenerative osteoarthritis or repeated trauma. CARTISTEM® is administered to through either a surgical method or an arthroscope. Approved by MFDS Korea in January, 2012 |
5. Images |
|
Division
Written by 전형옥